社论:病理学研究的体内和体外模型。

IF 2.3 4区医学 Q3 ONCOLOGY

Pathology & Oncology Research Pub Date : 2023-01-01 DOI:10.3389/pore.2023.1611196

Songwen Tan, Peter Nemeth

{"title":"社论:病理学研究的体内和体外模型。","authors":"Songwen Tan, Peter Nemeth","doi":"10.3389/pore.2023.1611196","DOIUrl":null,"url":null,"abstract":"JAK-STAT signaling pathway and apoptosis in rats. The study highlights the importance of investigating the baselines at different time points when assessing the therapeutic effect of drugs, as the pathological changes and protein expression can vary over time. The results suggest that JAK-STAT signaling pathway activation plays a vital role in RIRI and that apoptosis is","PeriodicalId":19981,"journal":{"name":"Pathology & Oncology Research","volume":null,"pages":null},"PeriodicalIF":2.3000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10111255/pdf/","citationCount":"0","resultStr":"{\"title\":\"Editorial: <i>In vivo</i> and <i>in vitro</i> models for research in pathology.\",\"authors\":\"Songwen Tan, Peter Nemeth\",\"doi\":\"10.3389/pore.2023.1611196\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"JAK-STAT signaling pathway and apoptosis in rats. The study highlights the importance of investigating the baselines at different time points when assessing the therapeutic effect of drugs, as the pathological changes and protein expression can vary over time. The results suggest that JAK-STAT signaling pathway activation plays a vital role in RIRI and that apoptosis is\",\"PeriodicalId\":19981,\"journal\":{\"name\":\"Pathology & Oncology Research\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":2.3000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10111255/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pathology & Oncology Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3389/pore.2023.1611196\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pathology & Oncology Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/pore.2023.1611196","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}

引用次数: 0

摘要

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Editorial: In vivo and in vitro models for research in pathology.

JAK-STAT signaling pathway and apoptosis in rats. The study highlights the importance of investigating the baselines at different time points when assessing the therapeutic effect of drugs, as the pathological changes and protein expression can vary over time. The results suggest that JAK-STAT signaling pathway activation plays a vital role in RIRI and that apoptosis is

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Pathology & Oncology Research 医学-病理学

CiteScore

6.30

自引率

0.00%

发文量

134

审稿时长

4-8 weeks

期刊介绍： Pathology & Oncology Research (POR) is an interdisciplinary Journal at the interface of pathology and oncology including the preclinical and translational research, diagnostics and therapy. Furthermore, POR is an international forum for the rapid communication of reviews, original research, critical and topical reports with excellence and novelty. Published quarterly, POR is dedicated to keeping scientists informed of developments on the selected biomedical fields bridging the gap between basic research and clinical medicine. It is a special aim for POR to promote pathological and oncological publishing activity of colleagues in the Central and East European region. The journal will be of interest to pathologists, and a broad range of experimental and clinical oncologists, and related experts. POR is supported by an acknowledged international advisory board and the Arányi Fundation for modern pathology.